Global Retirement Partners LLC increased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 109.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,621 shares of the biotechnology company’s stock after buying an additional 1,895 shares during the quarter. Global Retirement Partners LLC’s holdings in Axon Enterprise were worth $1,530,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. State Street Corp boosted its stake in Axon Enterprise by 5,700.2% during the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock valued at $119,724,905,000 after purchasing an additional 209,879,882 shares during the period. Envestnet Asset Management Inc. increased its stake in shares of Axon Enterprise by 18,050.2% in the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after purchasing an additional 13,127,348 shares during the period. BlackRock Inc. raised its stake in Axon Enterprise by 4.3% during the 2nd quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock valued at $4,672,432,000 after acquiring an additional 345,365 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its position in Axon Enterprise by 391,214.9% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock worth $2,952,943,000 after acquiring an additional 6,987,098 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its position in Axon Enterprise by 8,432.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock worth $1,983,414,000 after acquiring an additional 3,496,493 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several research analysts have recently issued reports on AXON shares. JPMorgan Chase & Co. decreased their price target on Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating for the company in a research note on Friday, November 6th. Craig Hallum cut Axon Enterprise from a “buy” rating to a “hold” rating and set a $390.00 target price on the stock. in a report on Friday, November 6th. Morgan Stanley increased their price target on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Barclays lowered their price target on Axon Enterprise from $688.00 to $507.00 and set an “overweight” rating on the stock in a research report on Monday, November 9th. Finally, Argus boosted their price objective on Axon Enterprise from $460.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, September 3rd. Thirteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $612.18.
Insider Transactions at Axon Enterprise
In other news, insider Isaiah Fields sold 1,017 shares of the business’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the sale, the insider owned 56,264 shares in the company, valued at $27,032,038.80. The trade was a 1.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the completion of the sale, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 27,792 shares of company stock valued at $15,214,581 over the last ninety days. Corporate insiders own 4.20% of the company’s stock.
Axon Enterprise Stock Performance
AXON opened at $291.13 on Friday. The company has a quick ratio of 2.60, a current ratio of 3.00 and a debt-to-equity ratio of 0.76. The firm has a market cap of $23.71 billion, a PE ratio of 93.31, a P/E/G ratio of 7.04 and a beta of 1.48. The business has a fifty day simple moving average of $398.48 and a 200-day simple moving average of $462.93. Axon Enterprise, Inc has a fifty-two week low of $289.68 and a fifty-two week high of $665.07.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Friday, November 6th. The biotechnology company reported $1.72 EPS for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The company had revenue of $908.55 million for the quarter, compared to analysts’ expectations of $934.33 million. During the same period in the prior year, the company earned $1.17 earnings per share. The company’s revenue for the quarter was up 27.8% on a year-over-year basis. As a group, equities analysts predict that Axon Enterprise, Inc will post 1.65 EPS for the current fiscal year.
Axon Enterprise Company Profile
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
Further Reading
- Five stocks we like better than Axon Enterprise
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
